The healthcare sector is up significantly after Merck and Moderna announced their experimental melanoma vaccine met its primary goals in a late-stage trial. This news has caused a surge in the stocks of both companies and other biotechnology firms, driving positive sentiment across the broader healthcare industry. This specific, positive catalyst is the primary driver of the sector's outperformance in an otherwise mixed broader market.